A randomized, double blind, parallel group, placebo controlled trial of Exenatide once weekly over 2 years as a potential disease modifying treatment for moderate severity Parkinson's disease

Project: Research

Project Details

Description

PI change from Dr Marios Politis to Prof Ray Chaudhuri, Nov 2019
Budget allocation (from DA to DI) change approved by NIHR 16 03 2020
Short titleEXENATIDE
StatusFinished
Effective start/end date1/01/201931/12/2023

Collaborative partners

Funding

  • NIHR National Institute For Health & Care Research: £47,402.11

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.